99 related articles for article (PubMed ID: 16246743)
1. Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: the appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results.
Hsiung CY; Hunt MA; Yorke ED; Chui CS; Hu J; Xiong JP; Ling CC; Lo SK; Wang CJ; Huang EY; Amols HI
Radiother Oncol; 2005 Oct; 77(1):53-7. PubMed ID: 16246743
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.
Teo PM; Ma BB; Chan AT
Radiother Oncol; 2004 Nov; 73(2):163-72. PubMed ID: 15542163
[TBL] [Abstract][Full Text] [Related]
3. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator.
Xiance J; Shixiu W; Jianyi Y; Jinling Y
Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation therapy for head and neck cancer.
Chou WW; Puri DR; Lee NY
Expert Rev Anticancer Ther; 2005 Jun; 5(3):515-21. PubMed ID: 16001958
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy.
Kristensen CA; Kjaer-Kristoffersen F; Sapru W; Berthelsen AK; Loft A; Specht L
Acta Oncol; 2007; 46(2):214-20. PubMed ID: 17453372
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
8. A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy.
Muren LP; Redpath AT; McLaren D; Rørvik J; Halvorsen OJ; Høstmark J; Bakke A; Thwaites D; Dahl O
Radiother Oncol; 2006 Jul; 80(1):98-105. PubMed ID: 16876274
[TBL] [Abstract][Full Text] [Related]
9. Sparing submandibular gland by IMRT.
Saibishkumar EP; Jha N
Radiother Oncol; 2006 Jul; 80(1):106. PubMed ID: 16876273
[No Abstract] [Full Text] [Related]
10. Intensity-modulated radiation therapy in the treatment of head and neck cancer.
Eisbruch A
Nat Clin Pract Oncol; 2005 Jan; 2(1):34-9. PubMed ID: 16264854
[TBL] [Abstract][Full Text] [Related]
11. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
[TBL] [Abstract][Full Text] [Related]
12. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
13. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
15. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
Ahmed M; Hansen VN; Harrington KJ; Nutting CM
Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
[TBL] [Abstract][Full Text] [Related]
16. Advances in radiotherapy for carcinoma of the head and neck.
Morris MM; Schmidt-Ullrich R; Johnson CR
Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
[TBL] [Abstract][Full Text] [Related]
18. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
20. [Determination of the repair half-time of human nasopharyngeal carcinoma cell lines CNE1, CNE2, HONE1 and C666-1].
Wang WJ; Zheng XK; Liu JB; Yuan YW; Chen LH; Sun HW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):777-8. PubMed ID: 20423849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]